Joel S. Lippman, M.D. v. Ethicon, Inc. (073324)

CourtSupreme Court of New Jersey
DecidedJuly 15, 2015
DocketA-65/66-13
StatusPublished

This text of Joel S. Lippman, M.D. v. Ethicon, Inc. (073324) (Joel S. Lippman, M.D. v. Ethicon, Inc. (073324)) is published on Counsel Stack Legal Research, covering Supreme Court of New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Joel S. Lippman, M.D. v. Ethicon, Inc. (073324), (N.J. 2015).

Opinion

SYLLABUS

(This syllabus is not part of the opinion of the Court. It has been prepared by the Office of the Clerk for the convenience of the reader. It has been neither reviewed nor approved by the Supreme Court. Please note that, in the interest of brevity, portions of any opinion may not have been summarized.)

Joel S. Lippman, M.D. v. Ethicon, Inc. and Johnson & Johnson, Inc. (A-65/66-13) (073324)

Argued January 20, 2015 -- Decided July 15, 2015

LaVECCHIA, J., writing for a unanimous Court.

In this appeal, the Court considers whether an employee, whose job duties entail knowing or securing compliance with a relevant standard of care and knowing when an employer’s actions or proposed actions deviate from that standard of care, may invoke the whistleblower protections afforded under N.J.S.A. 34:19-3 of the Conscientious Employee Protection Act (CEPA or Act), N.J.S.A. 34:19-1 to -14.

Plaintiff Joel S. Lippman, M.D., was employed by defendant Ethicon, Inc., a subsidiary of defendant Johnson & Johnson, Inc., a manufacturer of medical devices used for surgical procedures, from July 2000 until his termination in May 2006. For the majority of his employment, plaintiff served as worldwide vice president of medical affairs and chief medical officer of Ethicon. He was responsible for safety, medical reviews, and medical writing. Plaintiff served on multiple internal review boards, including a quality board that was created to assess the health risks posed by Ethicon’s products and provide medical input regarding any necessary corrective measures with respect to their products in the field.

On numerous occasions, plaintiff objected to the proposed or continued sale and distribution of certain Ethicon medical products on the basis that they were medically unsafe and that their sale violated various federal and state laws and regulations. In some instances, plaintiff opined that a particular product should not go to market, should be recalled, or that further research was necessary. Although he received “push back” from executives and other members of the boards whose interest and expertise aligned with Ethicon’s business priorities, Ethicon ultimately followed many of his recommendations. In April 2006, plaintiff advocated the recall of a particular product that he believed was dangerous, and it was eventually recalled in late April or early May 2006. On May 15, 2006, Ethicon terminated plaintiff’s employment.

Plaintiff filed a complaint alleging, in part, that his employment was terminated due to his whistleblowing activities, which he identified as his actions in reporting a number of products as dangerous and in violation of the federal Food, Drug and Cosmetic Act, and advising that defendants either recall the products or perform further research. Ethicon asserted that plaintiff was terminated as a result of an inappropriate relationship with someone who worked in a department under his authority. The trial court granted defendants’ summary judgment motion, dismissing plaintiff’s CEPA action. Relying on Massarano v. New Jersey Transit, 400 N.J. Super. 474 (App. Div. 2008), the court concluded that, because plaintiff admitted it was his job to bring forth issues regarding drug and product safety, he failed to show that he performed a whistleblowing activity protected by CEPA.

Plaintiff appealed, and the Appellate Division reversed in a published decision. Lippman v. Ethicon, Inc., 432 N.J. Super. 378 (App. Div. 2013). The panel rejected the trial court’s interpretation of protected whistleblowing conduct under N.J.S.A. 34:19-3(c), finding that it was inconsistent with the broad remedial purposes of CEPA. The panel noted that watchdog employees like plaintiff are the most vulnerable to retaliation because they routinely speak out when corporate profits are put ahead of consumer safety, and CEPA’s definition of an eligible employee does not limit protection based on job title or function. However, when addressing the standard for establishing a prima facie CEPA claim, the panel articulated an additional requirement for watchdog employees. Specifically, unless a watchdog employee refused to participate in the objectionable employer conduct, the employee must demonstrate that he or she pursued and exhausted all internal means of securing compliance. This Court granted defendants’ petition for certification and plaintiff’s cross-petition. 217 N.J. 292 (2014).

HELD: CEPA’s protections extend to the performance of regular job duties by watchdog employees. Unless and until the Legislature expresses its intent to differentiate among the classes of employees who are entitled to CEPA protection, there can be no additional burden imposed on watchdog employees seeking CEPA protection.

1. In order to determine whether plaintiff is entitled to bring a CEPA cause of action, the Court must construe CEPA’s language. In addressing this question of the Act’s meaning, the Court’s review is de novo. CEPA is remedial legislation entitled to liberal construction, with the purposes of protecting whistleblowers from retaliation by employers and discouraging employers from engaging in illegal or unethical workplace activities. N.J.S.A. 34:19-3 establishes the types of whistleblowing activity for which “an employer shall not take any retaliatory action against an employee.” An “employee,” as defined by N.J.S.A. 34:19-2(b), is “any individual who performs services for and under the control and direction of an employer for wages or other remuneration.” (pp. 21-25)

2. Turning to the question of whether watchdog employees like plaintiff are entitled to CEPA protection, the Court notes that CEPA’s plain language does not define employees protected by the Act as inclusive of only those with certain job functions. Moreover, New Jersey case law has extended the reach of N.J.S.A. 34:19-2(b), not restricted it. There is no support in CEPA’s definition of an “employee” to preclude its protection of watchdog employees. Restricting CEPA’s protection to a discrete class of employees would contravene two principles of statutory construction, namely that courts may not engraft language that the Legislature has not chosen to include in a statute and that remedial legislation should be liberally construed. (pp. 26-27)

3. The Court rejects defendants’ argument that watchdog employees must be acting outside the scope of their job duties in order to engage in CEPA-protected conduct under N.J.S.A. 34:19-3(c), which requires that a plaintiff “[o]bject[] to or refuse[] to participate in any activity, policy or practice. . . .” The plain meaning of the word “object” does not support defendants’ interpretation. Given that remedial legislation should be liberally construed, it would be wholly incongruent to strain the normal definition of “object” into some implicit requirement that limits a class of employee to whistleblower protection only for actions taken outside of normal job duties. This conclusion is further supported by subsection (c)’s corollary phrase “refuse[] to participate,” which implies that CEPA- protected conduct can occur within the course of an employee’s normal job duties. Furthermore, since neither subsection (a) nor (b) of N.J.S.A. 34:19-3 states or suggests that an employee must be acting outside of his or her usual duties to merit protection, it is inexplicable to assume that the Legislature would intend an implicit “job duties” exception excluding watchdog employees under subsection (c). (pp. 27-32)

4. To the extent that defendants and the trial court relied on Massarano v. New Jersey Transit, 400 N.J. Super. 474 (App. Div. 2008), for the proposition that watchdog employees are only entitled to CEPA protection if acting outside of the scope of their jobs, the Court finds that this argument lacks solid foundation.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pierce v. Ortho Pharmaceutical Corp.
417 A.2d 505 (Supreme Court of New Jersey, 1980)
Balsamides v. Protameen Chemicals, Inc.
734 A.2d 721 (Supreme Court of New Jersey, 1999)
State v. Sutton
625 A.2d 1132 (Supreme Court of New Jersey, 1993)
DiProspero v. Penn
874 A.2d 1039 (Supreme Court of New Jersey, 2005)
Mazzacano v. Estate of Kinnerman
962 A.2d 1103 (Supreme Court of New Jersey, 2009)
Dzwonar v. McDevitt
828 A.2d 893 (Supreme Court of New Jersey, 2003)
Estate of Roach v. Trw, Inc.
754 A.2d 544 (Supreme Court of New Jersey, 2000)
Feldman v. Hunterdon Radiological Associates
901 A.2d 322 (Supreme Court of New Jersey, 2006)
Mehlman v. Mobil Oil Corp.
707 A.2d 1000 (Supreme Court of New Jersey, 1998)
Hodges v. Sasil Corp.
915 A.2d 1 (Supreme Court of New Jersey, 2007)
Barratt v. Cushman & Wakefield of New Jersey, Inc.
675 A.2d 1094 (Supreme Court of New Jersey, 1996)
Abbamont v. Piscataway Township Board of Education
650 A.2d 958 (Supreme Court of New Jersey, 1994)
Fleming v. Correctional Healthcare Solutions, Inc.
751 A.2d 1035 (Supreme Court of New Jersey, 2000)
Lowe v. Zarghami
731 A.2d 14 (Supreme Court of New Jersey, 1999)
Allen v. v. AND a BROS., INC.
26 A.3d 430 (Supreme Court of New Jersey, 2011)
D'Annunzio v. Prudential Insurance Co. of America
927 A.2d 113 (Supreme Court of New Jersey, 2007)
Stomel v. City of Camden
927 A.2d 129 (Supreme Court of New Jersey, 2007)
Massarano v. New Jersey Transit
948 A.2d 653 (New Jersey Superior Court App Division, 2008)
Brill v. Guardian Life Insurance Co. of America
666 A.2d 146 (Supreme Court of New Jersey, 1995)
Donelson v. DuPont Chambers Works
20 A.3d 384 (Supreme Court of New Jersey, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Joel S. Lippman, M.D. v. Ethicon, Inc. (073324), Counsel Stack Legal Research, https://law.counselstack.com/opinion/joel-s-lippman-md-v-ethicon-inc-073324-nj-2015.